Group Leader: Hongli Hu

To optimize therapeutics with improved efficacy and/or reduced side-effect profiles

HuLab uses cryo‑EM technology to study protein targets involved in human diseases, including G protein–coupled receptor (GPCR) complexes and viral antigen–antibody complexes. This work provides a theoretical basis for drug design and supports the discovery of new therapeutics, as well as the development of related antibodies and vaccines.